First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry.
Luca GalliVincenzo Emanuele ChiuriGiuseppe Di LorenzoSalvatore PiscontiSabrina RossettiZuzana SirotovaAndrea MutoRoberto PetrioliMichele De TursiAndrea SbranaGiulio FrancoliniAntonio ArdizzoiaClaudio ScavelliFrancesco SattaSilvia QuadriniMario AiroldiCarmine D'AnielloAndrea BonettiSerafino ConfortiMichele AietaPatrizia BeccagliaAntonio MaestriLucia FratinoPublished in: Tumori (2022)
This investigation provided valuable information on the overall mCRPC treatment pattern and the effectiveness of first-line abiraterone and docetaxel in a population representative of everyday practice.